MMED net sales rise 16.6% to $843M; EBITDA improves
Net sales rose 16.6% to $843 million, driven by strong pump and CGM growth. Gross margin declined on a higher mix of lower-margin CGM products, while the net loss improved and Adjusted EBITDA more than doubled.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.